Proposed Bioequivalent Prompts Patent Assignee, Licensee To File Suit In New Jersey
TRENTON, N.J. — In a Nov. 30 complaint filed in the U.S. District Court for the District of New Jersey, the makers of VASCEPA — a brand name prescription medication that...To view the full article, register now.
Already a subscriber? Click here to view full article